R-Zero gathers $41.5m Series B

R-Zero, a biosafety technology company, has raised $41.5 million in Series B funding.

R-Zero, a biosafety technology company, has raised $41.5 million in Series B funding. World Innovation Lab led the round with participation from John Doerr, DBL Partners and SOSV/HAX.

Source: Press Release